Robert Ho

NGNE

Robert Ho serves as Chief Financial Officer at Neurogene Inc. (NGNE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$71.6K

Net Position

Net Seller

$71.6K

Companies Traded

NGNE

Active Period

Mar 2021

1 total trades

Most Recent

Sell NGNE

Mar 18, 2021 · $71.6K

Robert Ho's Insider Trading at Neurogene Inc. (NGNE)

Buys

0 · $0.00

Sells

1 · $71.6K

Total Shares Bought

Total Shares Sold

6,497

NGNE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 18, 2021	Sell	6,497	$11.01	$71.6K	21,503

Related Insiders

Christine Mikail Cvijic

officer: President and CFO

NGNESell · May 8, 2026

Julie Jordan

officer: Chief Medical Officer

NGNESell · Mar 30, 2026

Rachel McMinn

director, officer: Chief Executive Officer

NGNESell · Mar 30, 2026

Stuart Cobb

officer: Chief Scientific Officer

NGNESell · Mar 17, 2026

Explore More Insider Trading Data

NGNE Insider Trading Activity

View all insider trades at Neurogene Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity